Literature DB >> 2434840

Regulatory function of cell surface molecules CD2-, LFA- and beta 2-microglobulin in natural killer cell activity.

G G Petrányi, E Pócsik, B Kotlán, G Görög, M Benczur.   

Abstract

The functional importance of various cell membrane bound molecules was studied and compared in the NK cytotoxicity and CTL activity. LFA-1 and CD2 participate in both killing functions, while CD3 and CD8/CD4 as well as MHC class I molecules are involved only in CTL activity. Nevertheless CD2- and beta 2-microglobulin are representatives of the NK function. It was demonstrated that CD2-, LFA-1 and beta 2-microglobulin molecules have an additive and complementary function in the killing mechanism. The upregulation of alpha- and gamma-interferons on NK function seems not to be a consequence of the enhanced expression of these molecules on the cell surface induced by IF at the same time.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2434840     DOI: 10.1016/0161-5890(86)90164-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  Differential expression of lymphocyte function-associated antigen (LFA-1) on peripheral blood leucocytes from individuals with Down's syndrome.

Authors:  M J Barrena; P Echaniz; C Garcia-Serrano; P Zubillaga; E Cuadrado
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Adhesion of CD16+ K cells to antibody-coated targets is mediated by CD2 and CD18 receptors.

Authors:  J C Voltarelli; G Gjerset; C Anasetti
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

3.  Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific.

Authors:  R A Jones; S J Richards; D Patel; C S Scott
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

Review 4.  Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types.

Authors:  Elke M Muntjewerff; Luca D Meesters; Geert van den Bogaart; Natalia H Revelo
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.